Page 6 - நோய் ஆராய்ச்சி மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Jul 26, 2021 Do you sometimes lose your train of thought or feel a bit more anxious than is typical for you? Those are two of the six questions in a quiz on a website co-sponsored by the makers of Aduhelm, a controversial new Alzheimer’s drug. But even when all responses to the frequency of those experiences are “never,” the quiz issues a “talk to your doctor” recommendation about the potential need for additional cognitive testing. Facing a host of challenges, Aduhelm’s makers Biogen and its partner Eisai are taking a page right out of a classic marketing playbook: Run an educational campaign directed at the consumer, one who is already worried about whether those lost keys or a hard-to-recall name is a sign of something grave.

New yorkUnited statesVanderbilt universityJulie applebyJerry avornAllison parksMary sanoMaria carrilloAlfred sandrockMatthews schragAdriane fugh bermanPatrizia cavazzoniVanderbilt university medical centerGeorgetown university medical centerAlzheimer disease research centerDrug administration